| Study name | Year | Isolation SC/PC | AGEs application | Effect on outcome | | | | Concentration | Duration | Proliferation | Apoptosis |
| Bhatwadekar et al. [35] | 2008 | Human EPCs–peripheral blood, DGC | Fibronectin coated with 10, 50, & 100 μM MGO | 24 hours | ↘ | | Blackburn et al. [34] | 2017 | Human PBMC–peripheral blood, DGC | Collagen type I gel +1 mM MGO | 4 days | ↘ | | Chang et al. [36] | 2017 | Human EPCs–peripheral blood, DGC | 500 μg/ml | 24 hours | ↘ | | Chen et al. [37] | 2009 | Human EPCs–umbilical cord blood, DGC | 50, 100, 200, & 400 μg/ml | 24 hours | - | ↗ | Chen et al. [44] | 2019 | Human EPCs–peripheral blood, DGC | 200 μg/ml | 48 hours | ↘ | ↗ | Li et al. [38] | 2016 | Human EPCs–peripheral blood, DGC | 50, 100, & 200 μg/ml | 24, 48, and 72 hours | ↘ | | Liang et al. [39] | 2009 | Human EPCs–peripheral blood, DGC | 50, 100, & 200 μg/ml | 7 days | ↘ | ↗ | Scheubel et al. [40] | 2006 | Human EPCs–peripheral blood, DGC | 2, 20, & 200 μg/ml | 7 days | Low conc. ↗, high conc. ↘ | ↗ | Shen et al. [41] | 2010 | Human EPCs–peripheral blood, DGC | 2, 20, & 200 μg/l | 24, 48, and 72 hours | ↘ | ↗ | Sun et al. [42] | 2009 | Human EPCs–peripheral blood, DGC | 200 μg/ml | 24 hours | | ↗ | Zhu et al. [43] | 2012 | Human EPCs–peripheral blood, DGC | 15 to 3704 μg/l or 250 to 1000 μg/l | 24, 48, and 72 hours | ↘ | - |
|
|